CORONAVIRUS patients admitted to intensive care units are to get life-saving new treatments which can reduce the time spent in hospital by up to ten days, the Government has announced today. Results from the Government-funded REMAP-CAP clinical trial published today showed tocilizumab and sarilumab reduced the relative risk of death by 24 per cent, when administered to patients within 24 hours of entering intensive care. Most of the data came from when the drugs were administered in addition to a corticosteroid, such as dexamethasone, also discovered through government-backed research through the RECOVERY clinical trial, which is already provided as standard of care to the NHS. Patients receiving these drugs, typically used to treat rheumatoid arthritis, left intensive care between seven to ten days earlier on average.
7 January 2021
Government ensures life-saving drugs will be available in NHS healthcare settings with immediate effect
Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced today (Thursday 7 January).
Results from the government-funded REMAP-CAP clinical trial published today showed tocilizumab and sarilumab reduced the relative risk of death by 24%, when administered to patients within 24 hours of entering intensive care.
Most of the data came from when the drugs were administered in addition to a corticosteroid, such as dexamethasone – also discovered through government-backed research through the RECOVERY clinical trial – which is already provided as standard of care to the NHS.
Boris Johnson tonight hailed two life-saving arthritis drugs after a major British trial revealed they cut the risk of death in critically-ill Covid patients by nearly a quarter.
The PM who stumbled several times as he tried to pronounce them said the anti-inflammatory drugs tocilizumab and sarilumab would be made available through the NHS with immediate effect, potentially saving thousands of lives .
He told tonight s Downing Street press conference: I m pleased to tell you today British scientific research has now contributed to the creation of more new life-saving treatments that have just passed rigorous clinical trials. In particular, tocilizumab and sarilumab, and they ll shortly be on everybody s lips, which have been found to reduce the risk of death for critical ill patients by almost a quarter and they ve cut time spent in intensive care by as much as 10 days.
NHS to give first jabs of Oxford-AstraZeneca coronavirus vaccine from today liverpoolecho.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from liverpoolecho.co.uk Daily Mail and Mail on Sunday newspapers.